M&A Valuation

EBITDA Multiple Valuation in India: Sector Benchmarks

July 3, 2026

Part of the M&A Valuation Cluster Supporting guide within Elite Valuation's M&A series. For the full framework, read: M&A Valuation in India: Complete Guide

EBITDA multiple valuation is the market approach method most commonly used in Indian M&A, private equity transactions, and regulatory valuations. It translates a company's operating earnings into enterprise value by applying a sector specific multiple derived from listed peers or comparable transactions.

The method appears deceptively straightforward. In practice, the quality of the multiple depends entirely on the quality of the comparable selection, the accuracy of EBITDA normalisation, and the valuer's understanding of sector specific risk factors. An incorrectly selected multiple of even 2x can mean a difference of crores in a mid size deal.

This guide covers how EBITDA multiples work, what sector benchmarks apply in India as of 2026, how to normalise EBITDA before applying a multiple, and when an IBBI registered valuer is required to sign off the valuation for regulatory purposes.

Key Takeaways

  • EBITDA multiple valuation applies a sector specific EV/EBITDA multiple to normalised operating earnings to derive enterprise value.
  • Indian sector multiples range from 6x to 8x for traditional manufacturing to 25x to 40x for high growth SaaS and tech companies.
  • EBITDA must be normalised before a multiple is applied. One off items, related party distortions, and understated provisions must be removed.
  • A private company discount of 20% to 35% is typically applied to listed company multiples for unlisted Indian businesses.
  • An IBBI registered valuer is mandatory for valuations under the Companies Act 2013, FEMA, and SEBI regulations.
  • The method is unreliable for startups with negative EBITDA. Revenue multiples or DCF are preferred in those cases.
  • Multiple selection must be documented with comparable company analysis. Regulators and acquirers scrutinise this justification.

What Is EBITDA Multiple Valuation?

Definition: EBITDA Multiple Valuation

A market approach valuation method that estimates enterprise value by multiplying a company's normalised EBITDA by a sector derived EV/EBITDA multiple. The multiple is sourced from comparable listed companies (trading multiples) or precedent M&A transactions (transaction multiples).

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortisation. It represents operating cash generating capacity stripped of financing decisions and accounting policies, making it the most capital structure neutral profitability metric.

The multiple represents what the market is willing to pay per rupee of EBITDA in that sector. A technology company trading at 20x EBITDA means investors value the business at 20 times its annual operating earnings. The higher the multiple, the higher the growth expectations embedded in the price.

EBITDA Multiple Valuation: Enterprise Value Formula

Enterprise Value = Normalised EBITDA x Sector EV/EBITDA Multiple

Then:

Equity Value = Enterprise Value - Net Debt + Cash

Example: Manufacturing Company

Normalised EBITDA (FY25): Rs. 12.5 crore

Sector EV/EBITDA Multiple: 9x (mid tier manufacturing)

Enterprise Value: 12.5 x 9 = Rs. 112.5 crore

Less Net Debt: Rs. 18 crore

Equity Value: Rs. 94.5 crore

How Is EBITDA Normalised Before Applying a Multiple?

Applying a sector multiple to reported EBITDA without normalisation is one of the most common valuation errors in Indian M&A. Reported figures for unlisted companies frequently include items that overstate or understate sustainable earnings.

Normalisation adjusts reported EBITDA to reflect what the business would earn on a recurring, arm's length basis under a new owner. This adjusted figure is what the multiple should be applied to.

EBITDA Normalisation: Common Adjustments

Add back (upward adjustments):
  • One off legal, restructuring, or dispute related costs
  • Promoter salary above market rate charged to P&L
  • Transaction advisory fees expensed in the current year
Deduct (downward adjustments):
  • Revenue from related parties at above market pricing
  • Understated gratuity, leave encashment, or bad debt provisions
  • Non recurring government subsidies or one time grants
  • Rent concessions or costs not borne by the entity at arm's length

EBITDA Normalisation: Step by Step Example

Adjusted EBITDA = Reported EBITDA +/- Normalisation Items

Reported EBITDA (FY25): Rs. 18.5 crore

Add one off legal settlement: + Rs. 1.2 crore

Less related party revenue (above market pricing): - Rs. 2.8 crore

Less understated gratuity provision: - Rs. 0.9 crore

Normalised EBITDA: Rs. 16.0 crore (basis for multiple application)/h5>

Red Flag

If a company's reported EBITDA includes 30% or more revenue from related parties at non arm's length pricing, the normalised EBITDA will be materially lower. This is a common issue in Indian family businesses and requires careful review during financial due diligence before any multiple is applied.

What Are the Sector EBITDA Multiples in India (2026)?

The table below provides reference EV/EBITDA multiple ranges for major Indian sectors as of June 2026. These are derived from listed company trading multiples and recent precedent M&A transactions. Actual multiples applied in formal valuations require current benchmarking and professional judgement by an IBBI registered valuer.

Sector EV/EBITDA Range Driver of Multiple Typical Discount for Unlisted
Technology / SaaS 15x - 40x Recurring revenue, growth rate 25% - 35%
Pharmaceuticals 12x - 22x Pipeline, regulatory approvals 20% - 30%
FMCG 18x - 30x Brand strength, distribution 20% - 30%
Financial Services (NBFC) 8x - 15x AUM growth, credit quality 20% - 30%
Infrastructure / EPC 8x - 14x Order book, government contracts 20% - 25%
General Manufacturing 6x - 12x Capacity utilisation, margins 20% - 30%
Specialty Chemicals 10x - 18x Import substitution, exports 20% - 30%
Healthcare / Hospitals 14x - 25x Bed occupancy, ARPOB 20% - 30%
Logistics & Warehousing 10x - 18x Asset base, e-commerce exposure 20% - 25%
Education / EdTech 8x - 20x Student base, course diversification 25% - 35%
Real Estate (Developer) 8x - 15x Land bank, pre-sales, cycle stage 20% - 30%
Retail 7x - 14x Same-store growth, footprint 20% - 30%

Important Note on Multiple Ranges

These ranges reflect publicly available data from BSE/NSE listed companies and disclosed M&A transactions. For regulatory valuations (Companies Act, FEMA, SEBI), an IBBI registered valuer must independently derive the applicable multiple with documented comparable company analysis, not rely on reference ranges alone.

Need EBITDA Multiple Valuation Support?

IBBI registered valuers for M&A valuation, share transfer, and regulatory compliance across India.

How Are Comparable Companies Selected?

Multiple selection is the most judgement intensive step in EBITDA valuation. The quality of comparables directly determines the reliability of the output.

Comparable Company Selection: Criteria

A comparable company should match the target on as many of the following as possible:

  • Industry and sub-sector: A generic "manufacturing" peer is insufficient for a specialty chemical company
  • Revenue scale: Avoid comparing a Rs. 50 crore company to a Rs. 5,000 crore listed peer. Size premium distorts multiples
  • Growth profile: High growth companies trade at premium multiples. Match growth trajectory
  • EBITDA margin: Higher margin peers command higher multiples. Adjust if margins diverge significantly
  • Geography of operations: Pan-India vs. regional companies may attract different market premiums
  • Market liquidity: Highly liquid large cap comparables carry liquidity premium over unlisted targets

Minimum 5 comparables are required for a robust analysis. 8 to 10 is preferred for formal regulatory reports.

When listed Indian comparables are insufficient (thin market, niche sector), the valuer may supplement with global comparables adjusted for India specific country risk premiums or with precedent transaction multiples from disclosed Indian M&A deals.

What Is the Private Company Discount and How Is It Applied?

Listed company multiples incorporate a liquidity premium, which is the ability to buy and sell shares instantly at a transparent price. An unlisted private company does not offer this liquidity. The private company discount (also called discount for lack of marketability or DLOM) adjusts for this difference.

Definition: Private Company Discount (DLOM)

A percentage reduction applied to the multiple derived from listed comparable companies to reflect the illiquidity of unlisted private company shares. Standard range in Indian practice is 20% to 35%, depending on company size, shareholder base, and exit options available to investors.

The discount is applied to the multiple, not to the final enterprise value separately. A listed peer trading at 15x EBITDA with a 25% DLOM yields an applicable multiple of 11.25x for the unlisted target.

Factors that increase the discount include concentrated promoter shareholding with no secondary market, absence of a defined exit path, small revenue scale below Rs. 50 crore, and dependence on key man promoters. Factors that reduce it include institutional investor presence, documented succession plans, or an active M&A process underway.

Trading Multiples vs. Transaction Multiples: Which to Use?

Two datasets are available when deriving EBITDA multiples: current stock market prices of listed peers (trading multiples) and prices paid in historical M&A deals (transaction multiples). Both are valid, and each has a different application context.

Attribute Trading Multiples Transaction Multiples
Data Source BSE/NSE live prices Disclosed M&A deal terms
Reflects Minority stake market view Control premium paid by acquirer
Includes Control Premium No Yes (typically 20% to 40% above trading)
Best Used For Minority stake valuation, ESOP, FMV determination M&A deal pricing, full acquisition valuation
Data Availability in India Readily available for NSE/BSE listed companies Limited. Most Indian M&A deal values are undisclosed
Staleness Risk Low. Real time data High. Deals may be 2 to 5 years old

For most Indian regulatory valuations (share transfers, Section 62 allotments, FEMA pricing), trading multiples with a DLOM adjustment are the starting point. Transaction multiples are used to support or cross check in the context of full acquisitions.

When Is EBITDA Multiple Valuation Not Appropriate?

1. Startups with Negative EBITDA

Pre-profit companies with negative operating earnings cannot be valued using EBITDA multiples. Revenue multiples or DCF with terminal value are used instead, depending on the stage and investor expectations.

2. Highly Capital Intensive Businesses

Infrastructure, power, and heavy manufacturing companies require significant ongoing capex. EBITDA ignores capex, making EV/EBITDA a misleading metric. EV/EBIT or EV/EBITDA minus capex is more appropriate.

3. Financial Services Companies

Banks, NBFCs, and insurance companies have interest income as operating revenue. EBITDA is structurally inapplicable. Price to Book (P/B) or Price to AUM multiples are standard for these sectors.

4. Holding Companies and Conglomerates

Holding companies derive value from subsidiaries. A consolidated EBITDA multiple misses the sum of the parts value, particularly when subsidiaries operate in different sectors with different multiple profiles.

5. Companies with Highly Cyclical EBITDA

Commodity producers, real estate developers, and seasonal businesses may show distorted EBITDA in a single year. Trailing twelve month or normalised three year average EBITDA should be used, and even then, DCF may be more appropriate.

When Is an IBBI Registered Valuer Required?

EBITDA multiple valuation, when used for regulatory purposes in India, must be performed by or under the supervision of an IBBI registered valuer. The requirement is statutory, not a best practice recommendation.

IBBI Registered Valuer: Statutory Requirement

  • Companies Act, Section 62(1)(c): FMV for share allotments and rights issues must be certified by an IBBI registered valuer
  • Companies Act, Sections 230-232: Swap ratio for mergers and demergers requires IBBI registered valuer report for NCLT filing
  • Foreign Exchange Management (Non-Debt Instruments) Rules, 2019: Cross border share transfers require FMV by an IBBI registered valuer (DCF or NAV as mandated, EBITDA multiple may supplement)
  • SEBI ICDR Regulation 166A: Preferential allotments to acquirers in listed companies require IBBI registered valuer determination
  • Insolvency proceedings (IBC): Asset and business valuation for resolution plans requires IBBI registered valuer

The IBBI registered valuer's report must document the multiple selection methodology, the list of comparable companies or transactions used, adjustments made, and the rationale for any discounts applied. Regulators and transaction counterparties scrutinise this documentation closely.

How Does EBITDA Multiple Valuation Interact with DCF?

In formal valuations, EBITDA multiple valuation and DCF are typically used together as cross checks rather than in isolation. This is consistent with IBBI guidelines and standard valuation practice in Indian M&A.

The DCF produces an intrinsic value based on projected free cash flows discounted at WACC. The EBITDA multiple method produces a market referenced value based on what comparable businesses are currently priced at. If both methods produce values within 10% to 15% of each other, the valuation is internally consistent. A large divergence signals a need to review assumptions in one or both methods.

Triangulation Practice

A well constructed valuation report will present the EBITDA multiple range as the primary cross check against DCF, then weight the two outputs depending on the reliability of projections (DCF heavy for companies with strong forecast visibility) versus the quality of market comparables (multiple heavy for sectors with deep listed company data). The final FMV is typically the weighted average or midpoint of the two approaches, with the weighting explained and justified in the report.

What Are the Key Adjustments for India Specific Risks?

Indian company EBITDA multiples often require adjustments beyond the standard DLOM to reflect country specific and company specific risk factors that global benchmark multiples do not capture.

Risk Factor Direction of Adjustment Typical Range
Key Man Dependency (Promoter Driven) Downward 5% - 15% discount
Customer Concentration (>40% from Single Client) Downward 5% - 10% discount
Strong IP, Brand, or Proprietary Technology Upward 5% - 20% premium
Geographic Revenue Diversification Upward 3% - 10% premium
Regulatory Risk (Sector Under Investigation) Downward 10% - 25% discount
Strong Management Team with Defined Succession Upward 5% - 10% premium
Pending Litigation with Material Exposure Downward Case specific

Start Your EBITDA Valuation Today

IBBI certified valuers for M&A valuation, regulatory compliance, and sector benchmarking across India.

Closing Summary

EBITDA multiple valuation is the most widely used market approach in Indian M&A and remains the primary cross check to DCF in regulatory valuation reports. Its reliability depends on three things done well: rigorous EBITDA normalisation that reflects sustainable, arm's length earnings, disciplined comparable company selection with documented screening criteria, and an appropriately calibrated private company discount. The sector benchmarks in this guide provide a reference framework, but every formal valuation for regulatory purposes, whether under the Companies Act, FEMA, or SEBI, requires an IBBI registered valuer to independently derive and justify the applicable multiple. The valuation is only as defensible as the analysis behind the number.

Frequently Asked Questions: EBITDA Multiple Valuation

1What is EBITDA multiple valuation in India?
EBITDA multiple valuation estimates enterprise value by multiplying a company's EBITDA by a sector specific multiple derived from comparable listed companies or M&A transactions. It is one of the most widely used market approach methods in Indian M&A, PE deals, and regulatory valuations.
2What are typical EBITDA multiples for Indian companies?
Indian EBITDA multiples range widely by sector. Technology companies typically trade at 15x to 40x, pharma at 12x to 22x, manufacturing at 6x to 12x, FMCG at 18x to 30x, and infrastructure at 8x to 14x. These are reference ranges as of 2026 and require professional benchmarking for formal valuations.
3Is an IBBI registered valuer required for EBITDA based valuation?
Yes. For valuations under the Companies Act 2013 (Section 62, 192, 230-232), FEMA pricing guidelines, or SEBI regulations, an IBBI registered valuer is mandatory. The valuer must document the multiple selection rationale and comparable company analysis in their report.
4How is the right EBITDA multiple selected for a company?
The multiple is selected by identifying 5 to 10 comparable listed companies or precedent transactions in the same sector, adjusting for size, growth, margins, and liquidity. A private company discount (typically 20% to 35%) is then applied to reflect the illiquidity of unlisted shares.
5What is the difference between EV/EBITDA and P/E ratio?
EV/EBITDA measures enterprise value relative to operating earnings before interest, taxes, depreciation, and amortisation, making it capital structure neutral and ideal for M&A. P/E compares market capitalisation to net profit after tax and varies with leverage and tax, making cross company comparison less reliable.
6Can EBITDA multiple valuation be used for startup companies?
Rarely. Startups typically report negative or negligible EBITDA, making the method unreliable. Revenue multiples or DCF are preferred for early stage companies. The EBITDA method becomes applicable once the business reaches operational profitability, usually from Series B stage onwards.
7What are the limitations of EBITDA multiple valuation in India?
Key limitations include thin or illiquid comparables in Indian markets for niche sectors, EBITDA not reflecting capex intensity (critical for infrastructure or manufacturing), and related party or adjusted EBITDA figures in unlisted companies requiring a quality of earnings review before applying a multiple.
8How does normalisation affect the EBITDA multiple valuation?
Normalisation adjusts reported EBITDA to reflect sustainable, recurring earnings by removing one off items, related party pricing distortions, and understated provisions. A lower normalised EBITDA with the same multiple produces a lower enterprise value, directly impacting the deal price.

CA Sagar Shah, Founder

Mr Sagar Shah is the Founder of Elite Valuation and leads the firm’s Valuation and Advisory practice. With over 15+ years of professional experience.

Published Insights

Read Our Latest Blogs

✕
✕
✕
✕
Submit the form to download our Company Profile

    ✕
    Submit The Form to
    Download Free Resource

      ✕
      Submit the Form to Download Free CCM Valuation Excel Template

        ✕
        ✕
        ✕
        Submit the form to Download Valuation Board Presentation

          ✕

          Connect with Our Valuation & Advisory Experts

            Trusted By 500+ Clients

            ✕
            ✕
            Submit The Form to
            Access Free Tools

              ✕
              Submit The Form to
              Access Free Tools

                ✕
                Submit The Form to
                Download Free Resource

                  ✕
                  Submit The Form to
                  Download Free Resource

                    ✕
                    Call